Evaluation of two simulated AR exeragme prototype in virtual reality using two training concepts (endurance/strength endurance) for older people with hypertension

Evaluation of two simulated AR exeragme prototype in virtual reality using two training concepts (endurance/strength endurance) for older people with hypertension - BewARe – ARproto

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00022881

Enrollment

Registered

2020-09-07

Start date

2020-10-05

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I10

Interventions

Group 1: The study participants are examined on two test days. The investigation takes place by means of a VR headset, with which the participants can test and evaluate a simulated AR strength enduran

Eligibility

Sex/Gender

All

Age

65 Years to No maximum

Inclusion criteria

Inclusion criteria: • = 65 years • Diagnosed essential hypertension (grade I) • Independent mobility • Presence of subject information and signed consent

Exclusion criteria

Exclusion criteria: • Existence of legal support • MCI and severe cognitive impairments (TICS <31 pts.) • Increased risk of falling (Tinetti test <20 points) • Diseases associated with a high risk of falling (stroke, Parkinson's) • dizziness • Severe visual impairment • rice sickness • Pacemaker • Blood pressure at rest above 200/110 mmHg

Design outcomes

Primary

Measure	Time frame
The primary aim is to achieve the individual intensity of exertion. To achieve this, a comparison is made with the individually specified intensity of exertion by means of continuous pulse monitoring via a wearable. The study will take place in October 2020. Used assessments are: - Borg Scale (Borg, 1990) - NASA TLX (Task Load Index) (Xiao et al., 2005) Another primary aim is the evaluation of user friendliness. Used assessments are: - TUI-Post (Kothgassner et al., 2014) - UEQ (Laugwitz et al., 2009)	—

Measure

Time frame

The primary aim is to achieve the individual intensity of exertion. To achieve this, a comparison is made with the individually specified intensity of exertion by means of continuous pulse monitoring via a wearable. The study will take place in October 2020. Used assessments are: - Borg Scale (Borg, 1990) - NASA TLX (Task Load Index) (Xiao et al., 2005) Another primary aim is the evaluation of user friendliness. Used assessments are: - TUI-Post (Kothgassner et al., 2014) - UEQ (Laugwitz et al., 2009)

—

Secondary

Measure	Time frame
- Presence Questionnaire (PQ) (Witmer & Singer, 1998) - Immersive Tendencies Questionnaire (ITQ) (Witmer & Singer, 1998) - Simulator Sickness Questionnaire (SSQ) (Kennedy et al.,1993) - Gratch report scale (Gratch et al., 2007; Wang & Gratch, 2009) - Scale for the rating of Uncanny Valley effects (Ho & MacDorman, 2017) Guideline-based individual interviews on the following topic: - What was good/not so good? - What caused problems? - How was the training under VR glasses? - How was the overall duration? - Were the breaks sufficient? - How did you like the Avatar? - How do you rate the UI features?	—

Measure

Time frame

- Presence Questionnaire (PQ) (Witmer & Singer, 1998) - Immersive Tendencies Questionnaire (ITQ) (Witmer & Singer, 1998) - Simulator Sickness Questionnaire (SSQ) (Kennedy et al.,1993) - Gratch report scale (Gratch et al., 2007; Wang & Gratch, 2009) - Scale for the rating of Uncanny Valley effects (Ho & MacDorman, 2017) Guideline-based individual interviews on the following topic: - What was good/not so good? - What caused problems? - How was the training under VR glasses? - How was the overall duration? - Were the breaks sufficient? - How did you like the Avatar? - How do you rate the UI features?

—

Countries

Germany

Contacts

Public ContactSusan Vorwerg

Charité Universitätsmedizin Berlin - Forschungsgruppe Geriatrie

susan.vorwerg@charite.de+49 30 450 565 096

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 10, 2026